Skip to content
DataLookout
Menu

Spinogenix clinical trial pipeline

Get alerts when Spinogenix's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-06

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable: Effects and Safety of Codabakalner · FXS in Male Participants and Adult Participants With ADS Enrollment reduced: 248 → 120 participants SpinogenixPhase 2/3 NCT07439510
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 2
2
Phase 2/3
2

Disease areas by active trials

Get alerts when Spinogenix's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free